Positional Mapping and Candidate Gene Analysis of the Mouse Ccs3 Locus That Regulates Differential Susceptibility to Carcinogen-Induced Colorectal Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Meunier, Charles ^a   van der Kraak, Lauren ^a   Turbide, Claire ^b   Groulx, Normand ^a   Labouba, Ingrid ^c   Cingolani, Pablo ^d   Blanchette, Mathieu ^d   Yeretssian, Garabet ^a   Mes Masson, Anne Marie ^c   Saleh, Maya ^a   Beauchemin, Nicole ^a,b   Gros, Philippe ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NUCLEAR FACTOR KAPPA B1 P105; NUCLEAR FACTOR KAPPA B1 P50; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHROMOSOME 3; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC RECOMBINATION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRON; MACROPHAGE; MALE; MOUSE; NFKB1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECOMBINANT CONGENIC STRAIN; RNA SPLICING; SEQUENCE ALIGNMENT; SLC39A8 GENE;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYBRIDIZATION, GENETIC; INBREEDING; INTESTINAL MUCOSA; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B P50 SUBUNIT; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 84875026719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058733     Document Type: Article

References (77)

1. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C, (2003) The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3: 695-701.
2. Fearon ER, Vogelstein B, (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
3. Demant P, (2003) Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev Genet 4: 721-734.
4. Cazier J-B, Tomlinson I, (2010) General lessons from large-scale studies to identify human cancer predisposition genes. The Journal of pathology 220: 255-262.
5. Fletcher O, Houlston RS, (2010) Architecture of inherited susceptibility to common cancer. Nature Reviews Cancer 10: 353-361.
6. Quigley D, Balmain A, (2009) Systems genetics analysis of cancer susceptibility: from mouse models to humans. Nat Rev Genet 10: 651-657.
7. de la Chapelle A, (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4: 769-780.
8. Abraham C, Cho JH, (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
9. Lubbe SJ, Whiffin N, Chandler I, Broderick P, Houlston RS, (2011) Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3,146 patients. Carcinogenesis 33: 108-112.
10. NCI- Genetics of CRC. Available: http://www.cancer.gov/cancertopics/pdq/genetics/colorectal/HealthProfessional.Accessed: 2012 October 1.
11. Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, et al. (2010) Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nature genetics 42: 973-977.
12. Tomlinson IPM, Carvajal-Carmona LG, Dobbins SE, Tenesa A, Jones AM, et al. (2011) Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet 7: e1002105.
13. Tenesa A, Dunlop MG, (2009) New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 10: 353-358.
14. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
15. Franke A, Mcgovern DPB, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genet 42: 1118-1125.
16. Mcgovern DPB, Gardet A, Törkvist L, Goyette P, Essers J, et al. (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nature genetics 42: 332-337.
17. Terzić J, Grivennikov S, Karin E, Karin M, (2010) Inflammation and colon cancer. Gastroenterology 138: 2101-2114.e2105.
18. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
19. Brand S, (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
20. Van Limbergen J, Wilson DC, Satsangi J, (2009) The genetics of Crohn's disease. Annual review of genomics and human genetics 10: 89-116.
21. Dragani TA, (2003) 10 years of mouse cancer modifier loci: human relevance. Cancer research 63: 3011-3018.
22. Bissahoyo A, Pearsall RS, Hanlon K, Amann V, Hicks D, et al. (2005) Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Toxicol Sci 88: 340-345.
23. Suzui M, Okuno M, Tanaka T, Nakagama H, Moriwaki H, (2002) Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. Cancer letters 183: 31-41.
24. Takahashi M, Wakabayashi K, (2004) Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95: 475-480.
25. Nambiar PR, Girnun G, Lillo NA, Guda K, Whiteley HE, et al. (2003) Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. International journal of oncology 22: 145-150.
26. Jacoby RF, Hohman C, Marshall DJ, Frick TJ, Schlack S, et al. (1994) Genetic analysis of colon cancer susceptibility in mice. Genomics 22: 381-387.
27. Fijneman RJ, Demant P, (1995) A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4. Cancer research 55: 3179-3182.
28. Angel JM, Popova N, Lanko N, Turusov VS, DiGiovanni J, (2000) A locus that influences susceptibility to 1, 2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3. Mol Carcinog 27: 47-54.
29. Moen CJ, Groot PC, Hart AA, Snoek M, Demant P, (1996) Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci USA 93: 1082-1086.
30. Ruivenkamp CAL, Csikós T, Klous AM, van Wezel T, Demant P, (2003) Five new mouse susceptibility to colon cancer loci, Scc11-Scc15. Oncogene 22: 7258-7260.
31. Ruivenkamp CAL, van Wezel T, Zanon C, Stassen APM, Vlcek C, et al. (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nature genetics 31: 295-300.
32. Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, et al. (2003) LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 22: 3472-3474.
33. Meunier C, Cai J, Fortin A, Kwan T, Marquis JF, et al. (2010) Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3. Oncogene 29: 647-661.
34. Meunier C, Kwan T, Turbide C, Beauchemin N, Gros P, (2011) Genetic Control of Susceptibility to Carcinogen-Induced Colorectal Cancer in Mice: The Ccs3 and Ccs5 Loci Regulate Different Aspects of Tumorigenesis. Cell Cycle 10: 1739-1749.
35. Van Der Kraak L, Meunier C, Turbide C, Jothy S, Gaboury L, et al. (2010) A two-locus system controls susceptibility to colitis-associated colon cancer in mice. Oncotarget 1: 436-446.
36. Sanger Mouse Genome Re-sequencing. Available: http://www.sanger.ac.uk/resources/mouse/genomes/.Accessed 2012 October 1.
37. Alkhayat AH, Kraemer SA, Leipprandt JR, Macek M, Kleijer WJ, et al. (1998) Human beta-mannosidase cDNA characterization and first identification of a mutation associated with human beta-mannosidosis. Human molecular genetics 7: 75-83.
38. Yeretssian G, Correa RG, Doiron K, Fitzgerald P, Dillon CP, et al. (2011) Non-apoptotic role of BID in inflammation and innate immunity. Nature 474: 96-99.
39. Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson MM, et al. (2007) Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. The Journal of experimental medicine 204: 511-524.
40. Black DL, (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
41. Laurencikiene J, Källman AM, Fong N, Bentley DL, Ohman M, (2006) RNA editing and alternative splicing: the importance of co-transcriptional coordination. EMBO Rep 7: 303-307.
42. Buratti E, Baralle FE, (2004) Influence of RNA secondary structure on the pre-mRNA splicing process. Mol Cell Biol 24: 10505-10514.
43. Landt SG, Ramirez A, Daugherty MD, Frankel AD, (2005) A simple motif for protein recognition in DNA secondary structures. Journal of molecular biology 351: 982-994.
44. Spiro C, McMurray CT, (1997) Switching of DNA secondary structure in proenkephalin transcriptional regulation. The Journal of biological chemistry 272: 33145-33152.
45. Sutherland GR, Richards RI, (1995) Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci USA 92: 3636-3641.
46. Kunkel TA, (1993) Nucleotide repeats. Slippery DNA and diseases. Nature 365: 207-208.
47. Balkwill GD, Williams HEL, Searle MS, (2007) Structure and folding dynamics of a DNA hairpin with a stabilising d(GNA) trinucleotide loop: influence of base pair mis-matches and point mutations on conformational equilibria. Org Biomol Chem 5: 832-839.
48. Naugler WE, Karin M, (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26.
49. Beinke S, Ley SC, (2004) Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382: 393-409.
50. Lin L, DeMartino GN, Greene WC, (1998) Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92: 819-828.
51. Tong X, Yin L, Washington R, Rosenberg DW, Giardina C, (2004) The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 265: 171-183.
52. Pacifico F, Leonardi A, (2006) NF-kappaB in solid tumors. Biochem Pharmacol 72: 1142-1152.
53. Ben-Neriah Y, Karin M, (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 12: 715-723.
54. Karban AS, Okazaki T, Panhuysen CIM, Gallegos T, Potter JJ, et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Human molecular genetics 13: 35-45.
55. Greten FR, Eckmann L, Greten TF, Park JM, Li Z-W, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
56. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, et al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561.
57. Pasparakis M, (2009) Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol 9: 778-788.
58. Greten F, Arkan M, Bollrath J, Hsu L, Goode J, et al. (2007) NF-[kappa] B Is a Negative Regulator of IL-1 [beta] Secretion as Revealed by Genetic and Pharmacological Inhibition of IKK [beta]. Cell 130: 918-931.
59. Bruey J-M, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, et al. (2007) Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129: 45-56.
60. Hsu L-C, Enzler T, Seita J, Timmer AM, Lee C-Y, et al. (2011) IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ. Nat Immunol 12: 144-150.
61. Gilmore TD, (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115: 241-265.
62. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, et al. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359: 339-342.
63. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, et al. (1991) B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 67: 1075-1087.
64. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, et al. (2000) Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6: 961-967.
65. Staudt LM, (2010) Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol 2: a000109.
66. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, et al. (2007) Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12: 131-144.
67. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471: 467-472.
68. Maeda S, Kamata H, Luo J-L, Leffert H, Karin M, (2005) IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990.
69. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643.
70. Inokuchi S, Aoyama T, Miura K, Osterreicher CH, Kodama Y, et al. (2010) Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci USA 107: 844-849.
71. Bettermann K, Vucur M, Haybaeck J, Koppe C, Janssen J, et al. (2010) TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell 17: 481-496.
72. Dalton TP, He L, Wang B, Miller ML, Jin L, et al. (2005) Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. Proc Natl Acad Sci USA 102: 3401-3406.
73. Network CGA, (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
74. Gálvez-Peralta M, He L, Jorge-Nebert LF, Wang B, Miller ML, et al. (2012) ZIP8 zinc transporter: indispensable role for both multiple-organ organogenesis and hematopoiesis in utero. PLoS ONE 7: e36055.
75. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, et al. (2001) Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74: 21-35.
76. Marquis J-F, Kapoustina O, Langlais D, Ruddy R, Dufour CR, et al. (2011) Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet 7: e1002097.
77. Reeder J, Giegerich R, (2004) Design, implementation and evaluation of a practical pseudoknot folding algorithm based on thermodynamics. BMC Bioinformatics 5: 104.